Sphinx Trading’s Intersect ENT, Inc XENT Stock Holding History

Sphinx Trading’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$191K	Hold	7,000	–	–	0.19%	63
2021 Q3	$190K	Buy	+7,000	New	+$173K	0.2%	59

Other funds holding XENT

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KLCMU

Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Sphinx Trading's XENT Position: Q4 2021 in Review

Sphinx Trading held its Intersect ENT, Inc (XENT) position steady in Q4 2021 at 7,000 shares worth $191K. The position accounts for 0.19% of the portfolio, ranked #63.

Sphinx Trading first reported a position in XENT in Q3 2021 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.

Sphinx Trading held 7,000 shares of Intersect ENT, Inc worth $191K as of Q4 2021.
Sphinx Trading left its Intersect ENT, Inc share count unchanged in Q4 2021.
Intersect ENT, Inc made up 0.19% of Sphinx Trading's portfolio in Q4 2021, its #63 holding.
Sphinx Trading first reported a position in Intersect ENT, Inc in Q3 2021 and has held it in 2 quarters since.
121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.

Based on Sphinx Trading's 13F filing for Q4 2021, filed 31 Jan 2022.